Use of 24-Hour Ambulatory Blood Pressure Monitoring to Assess Antihypertensive Efficacy: A Comparison of Olmesartan Medoxomil, Losartan Potassium, Valsartan, and Irbesartan

By Smith David H.G.   Dubiel Robert   Jones Michael  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 41-50

Adis International

Access to resources Recommend Favorite

Antihypertensive Effects of Olmesartan Compared with Other Angiotensin Receptor Blockers: A Meta-Analysis

By Wang Long  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 5, 2012-10 ,pp. : 335-344

Adis International

Access to resources Recommend Favorite

Dose-Response Characteristics of Olmesartan Medoxomil and Other Angiotensin Receptor Antagonists

By Smith David H.G.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 5, 2007-01 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite

A randomized, naturalistic cost-effectiveness study in a managed health care setting

By Heiligenstein J.H.   Simon G.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 256-257

Elsevier

Access to resources Recommend Favorite

Effects of Olmesartan Medoxomil, an Angiotensin II Type 1 Receptor Antagonist, on Plasma Concentration of B-Type Natriuretic Peptide, in Hypertensive Patients with Type 2 Diabetes Mellitus: A Preliminary, Observational, Open-Label Study

By Kawai Toshihide   Takei Izumi   Shimada Akira  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 237-245

Adis International

Access to resources Recommend Favorite